NEU neuren pharmaceuticals limited

Ann: Neuren initiates development of NNZ-2591 to treat HIE, page-16

  1. 2,650 Posts.
    lightbulb Created with Sketch. 788
    I agree. They've got a few opportunities, and this one is at the top of the funnel probably for very good reason.

    I wonder how they do mouse models on an acquired brain injury vs a genetic mutation. I am thinking about the poor mouse biggrin.png
    (Ps: In case anyone wonders - I am joking, any harm to these test mice can potentially help thousands of human children!)
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$17.78
Change
0.230(1.31%)
Mkt cap ! $2.240B
Open High Low Value Volume
$17.83 $17.99 $17.35 $16.12M 911.8K

Buyers (Bids)

No. Vol. Price($)
2 11000 $17.40
 

Sellers (Offers)

Price($) Vol. No.
$17.80 10070 2
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.